The global orthopedic biomaterials market size was valued at USD 11.96 billion in 2018 and is anticipated to expand at a CAGR of 10.3% over the forecast period. Increasing incidence of musculoskeletal ailments and chronic skeletal conditions is boosting the product demand, thereby augmenting the market growth. The rising geriatric population, which is highly susceptible to these conditions, is expected to bolster the demand further. Rise in the number of trauma cases arising from accidents, fall and sports is another factor responsible for the growing demand for orthopedic biomaterials. As more and more people are engaging in sport and recreational activities, the risk of injuries is increasing.